Original Article
 

Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling

Abstract

Signaling AMP-activated protein kinase (AMPK), an energy sensing enzyme, has been implicated in controlling inflammation. In this study we investigated whether activation of AMPK by metformin could protect the lung from lipopolysaccharide (LPS)-induced acute injury by inhibitingng TLR4 pathway. Male Wistar rats were randomly divided into 3 groups (n=6): control group received normal saline (0.5 mL), LPS group received LPS (0.5 mg/kg), and metformin-treated group received LPS and metformin (100 mg/kg). Nine hours later nuclear factor-κB (NF-κB), phosphorylated, and non-phosphorylated AMPK using western blot, and the rate of TLR4 mRNA expression using real-time PCR were assessed in the lung tissue. To evaluate neutrophil infiltration, the myeloperoxidase (MPO) activity was measured. The severity of the lung damage was assessed by histological examinations. It was found that the ratio of p-AMPKα to AMPKα was significantly upregulated by 22% (p<0.05) in the lungs obtained from the metformin group. In LPS-treated rats, we observed a high expression of TLR4 in the tissue along with increased levels of MyD88, NF-κB, and TNFα. Metformin considerably reduced all these parameters. Histological examinations revealed that metformin remarkably attenuated congestion and inflammatory cellular infiltration into the alveolar walls and also decreased MPO activity by 37% (p<0.05). We conclude that metformin could protect the lung tissue against LPS-evoked TLR4 activation and the protective effect can be related to the activation of AMPK.

1. Russell JA. Management of sepsis. N Engl J Med 2006;355(16):1699-713.

2. Garber BG, Hebert PC, Yelle JD, Hodder RV, McGowan J. Adult respiratory distress syndrome: a systemic overview of incidence and risk factors. Crit Care Med 1996; 24(4):687-95.

3. Janardhan KS, McIsaac M, Fowlie J, Shrivastav A, Caldwell S, Sharma RK, et al. Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol Histopathol 2006; 21(7):687-96.

4. Reaves TA, Chin AC, Parkos CA. Neutrophil transepithelial migration: role of toll-like receptors in mucosal inflammation. Mem Inst Oswaldo Cruz 2005;100 Suppl 1:191-8.

5. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-76.

6. Rameshrad M, Maleki-Dizaji N, Vaez H, Soraya H, Nakhlband A, Garjani A. Lipopolysaccharide Induced Activation of Toll Like Receptor 4 in Isolated Rat Heart Suggests a Local Immune Response in Myocardium. Iran J Immunol 2015; 12(2):104-16.

7. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 2012; 4(3).

8. Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S.Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 2009; 182(12):8005-14.

9. Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaBH. Vaez, et al.activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006;47(6):1183-8.

10. Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Kim KR, et al. Metformin suppresses lipopolysaccharide (LPS)- induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem 2014; 289(33):23246-55.

11. Yuan H, Li L, Zheng W, Wan J, Ge P, Li H, et al.Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. Int Immunopharmacol 2012; 12(4):682-8.

12. Hafezzadeh H, Soraya H, Banani A, Adibpour M, Rameshrad M, Garjani A, et al. The Effect of Metformin on Neutrophil Recruitment in Carrageenan- Induced Peritonitis in Mice. Pharma Sci 2012; 17(4):209-18.

13. Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol 2011;162(7):1498-508.

14. Soraya H, Farajnia S, Khani S, Rameshrad M, Khorrami A, Banani A, et al. Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are enhances recovery of left ventricular mechanical function. J Mol Cell Cardiol 2012; 52(6):1308-18.

21. Kewalramani G, An D, Kim MS, Ghosh S, Qi D, Abrahani A, et al. AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin- deficient diabetes. J Mol Cell Cardiol 2007; 42(2):333-42.

22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.

23. Zhang Q, Qian FH, Yin XW, Cao Q, Bai JL, Du Q, et al.Associations of Toll-like receptor 7 and 8 Polymorphisms with Asthma and Asthma-related Phenotypes in a Chinese Han Population. Iran J Allergy Asthma Immunol 2015;14(6):569-80.

24. Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I.5-aminoimidazole-4-carboxamide ribonucleoside: a novel mmunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol 2005; 175(1):566-74.

25. Paintlia AS, Paintlia MK, Singh I, Singh AK.Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta- D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. Am J AMPK and TLRs connected? Int Immunopharmacol 2012; 14(4):785-91.

15. Vaez H, Rameshrad M, Najafi M, Barar J, Barzegari A, Garjani A. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Eur J Pharmacol 2016; 772:115-23.

16. Zhu MY, Lu YM, Ou YX, Zhang HZ, Chen WX.Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model. J Dig Dis 2012; 13(8):421-9.

17. Liu Y, Yang G, Bu X, Liu G, Ding J, Li P, et al. Cell- type-specific regulation of raft-associated Akt signaling. Cell Death Dis 2011; 2:e145.

18. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14(3):157-67.

19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29(9):e45.

20. Omar MA, Verma S, Clanachan AS. Adenosine-mediated inhibition of 5'-AMP-activated protein kinase and p38 mitogen-activated protein kinase during reperfusion enhances recovery of left ventricular mechanical function. J Mol Cell Cardiol 2012; 52(6):1308-18

21. Kewalramani G, An D, Kim MS, Ghosh S, Qi D, Abrahani A, et al. AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin- deficient diabetes. J Mol Cell Cardiol 2007; 42(2):333-42.

22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.

23. Zhang Q, Qian FH, Yin XW, Cao Q, Bai JL, Du Q, et al.Associations of Toll-like receptor 7 and 8 Polymorphisms with Asthma and Asthma-related Phenotypes in a Chinese Han Population. Iran J Allergy Asthma Immunol 2015;14(6):569-80.

24. Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I.5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol 2005; 175(1):566-74.

25. Paintlia AS, Paintlia MK, Singh I, Singh AK.Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta- D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. Am J AMPK and TLRs connected? Int Immunopharmacol 2012; 14(4):785-91.

15. Vaez H, Rameshrad M, Najafi M, Barar J, Barzegari A, Garjani A. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Eur J Pharmacol 2016; 772:115-23.

16. Zhu MY, Lu YM, Ou YX, Zhang HZ, Chen WX.Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model. J Dig Dis 2012; 13(8):421-9.

17. Liu Y, Yang G, Bu X, Liu G, Ding J, Li P, et al. Cell- type-specific regulation of raft-associated Akt signaling. Cell Death Dis 2011; 2:e145.

18. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14(3):157-67.

19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29(9):e45.

20. Omar MA, Verma S, Clanachan AS. Adenosine-mediated inhibition of 5'-AMP-activated protein kinase and p38 mitogen-activated protein kinase during reperfusion Pathol 2006; 169(3):1012-25.

26. Sag D, Carling D, Stout RD, Suttles J. Adenosine 5'- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008; 181(12):8633-41.

27. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108(8):1167-74.

28. Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, et al. Indices of low- grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 2006; 21(6):1426-31.

29. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001; 107(1):7-11.

30. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, et al. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther 2006; 316(3):1053-61.

31. Iraz M, Iraz M, Esrefoglu M, Aydin MS. Protective effect of beta-glucan on acute lung injury induced by lipopolysaccharide in rats. Turk J Med Sci 2015;45(2):261-7.

32. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 2003; 111(7):1011-20.

Files
IssueVol 15, No 6 (2016) QRcode
SectionOriginal Article(s)
Keywords
AMP-activated protein kinase Lipopolysaccharide Lung Metformin Sepsis Toll-like receptors

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Vaez H, Najafi M, Toutounchi NS, Barar J, Barzegari A, Garjani A. Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling. Iran J Allergy Asthma Immunol. 2017;15(6):498-507.